M&A Deal Summary |
|
|---|---|
| Date | 2011-07-15 |
| Target | Ortho Dermatologics |
| Sector | Consumer Products |
| Buyer(s) | Bausch Health |
| Sellers(s) | Janssen Pharmaceuticals |
| Deal Type | Divestiture |
| Deal Value | 345M USD |
SEARCH BY
| Category | Company |
|---|---|
| Sector | Life Science |
| Employees | 20,270 |
| Revenue | 9.6B USD (2024) |
Bausch Health is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology, and branded generics. Bausch Health is based in Laval, Quebec.
| DEAL STATS | # |
|---|---|
| Overall | 13 of 36 |
| Sector: Consumer Products M&A | 3 of 6 |
| Type: Divestiture M&A Deals | 5 of 9 |
| State: New Jersey M&A | 3 of 5 |
| Country: United States M&A | 6 of 23 |
| Year: 2011 M&A | 5 of 7 |
| Size (of disclosed) | 12 of 28 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-07-11 |
Dermik Laboratories
Bridgewater, New Jersey, United States Dermik Laboratories, Inc. portfolio includes major therapeutic and aesthetic dermatology brands such as Benzaclin® for the treatment of acne, Carac® for the treatment of keratoses and Sculptra®, a facial injectable for the correction of facial wrinkles and folds. |
Buy | $425M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-08-19 |
Sanitas AB
Kaunas, Lithuania Sanitas AB is a branded generic pharmaceutical company focused on specialty therapeutic segments. Company are vertically integrated across formulation development, registration, manufacturing and sales and marketing. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 1973 |
| Sector | Life Science |
Janssen Pharmaceuticals, Inc., a pharmaceutical company of Johnson & Johnson, provides medicines for an array of health concerns in several therapeutic areas, including: attention deficit hyperactivity disorder (ADHD), general medicine (acid reflux disease, infectious diseases), mental health (bipolar I disorder, schizophrenia), neurologics (Alzheimer’s disease, epilepsy, migraine prevention and treatment), pain management, and women’s health.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 3 |
| Sector: Consumer Products M&A | 1 of 2 |
| Type: Divestiture M&A Deals | 2 of 3 |
| State: New Jersey M&A | 1 of 1 |
| Country: United States M&A | 1 of 2 |
| Year: 2011 M&A | 2 of 2 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-03-14 |
Janssen Pharmaceuticals - Animal Health Business
Beerse, Belgium Janssen Pharmaceuticals - Animal Health Business is primarily European-focused, targeting disease segments in companion animals and livestock, with special emphasis on swine and poultry. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-11-20 |
INCIVO
United States INCIVO is a prescription medicine used with the medicines peginterferon alfa and ribavirin to treat chronic (lasting a long time) hepatitis C genotype 1 infection in adults with stable liver problems, who have not been treated before or who have failed previous treatment. |
Buy | $152M |
